Discusses Unlocking Business Value and Growth Opportunities in Modern ALM July 15, 2026 9:00 AM EDTCompany ParticipantsOliver ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results